Add this topic to your myFT Digest for news straight to your inbox
Frontline doctors forced to take time off work as they struggle to secure family coronavirus results
The $5 kit can confirm in as little as 15 minutes whether someone has Covid-19
Pharmaceutical groups call for ‘mutual recognition’ to avoid duplicating processes
Kai Chen’s masters in management and global network were key to sourcing safety equipment for Canada
Hospital group wards off debt-claim enforcement to allow it to remain open as virus surges in Gulf
Survey of dialysis patients indicates majority may not have an immune response despite high infection numbers
Prime minister wants Britain to take bigger role in global fight against pandemic
Separate data show growth in new daily infections across the UK has risen to between 4% and 8%
Infecting UK volunteers with coronavirus requires maximum transparency
Industrial company says it has developed a test that can deliver results in under 40 minutes
Senior doctor’s assessment clashes with warnings that disease is ‘ripping through’ country
US president outlines healthcare policy vision but gives little detail on how to implement it
People’s intentions to follow the guidelines are much greater than their actions, study finds
US state’s governor warns federal process for approving jab has become too politicised
Government hopes stockpile of PPE will help NHS avoid shortages of first wave of virus
Fauci and Redfield push back on Trump’s more optimistic projections at Senate hearing
State hospitals owe $2.3bn to global pharma and medical groups, American ambassador says
Company raised $1.1bn in initial public offering, giving it valuation of nearly $12.7bn
‘Human challenge trials’ intended to accelerate vaccine development programmes
Out of 300 candidates, nine are in phase 3 trials, with some hoping for emergency use approval this year
World’s largest healthcare company hopes to catch rivals working on two-jab products
Stricter FDA guidelines make it unlikely one will be approved before November election
Experts fear damage to public trust as tests remain on hold in US but restart elsewhere
International Edition
